SEATTLE & INNSBRUCK, Austria, May 20, 2024 Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005 (ebselen) trial is to reduce the loss of residual hearing during and after CI. Ebselen is a novel anti-inflammatory compound that mimics and induces the activity of Glutathione Peroxidase, an enzyme that is c
On sonic symphony and heartfelt honors philstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philstar.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Today, MED-EL, a leader in implantable hearing solutions, celebrates together with everyone living with and benefiting from cochlear implants..
/PRNewswire/ MED-EL, a leading provider and inventor of hearing implant systems, today launched its annual worldwide search for inventions of the future.
New Delhi [India], July 28 (ANI/PRNewswire): Today a network of volunteers in India who support people living with hearing loss have become part of a global online community.